Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 205 entries
Sorted by: Best Match Show Resources per page
[Diagnostic procedure, from art to science: what role has the computer?].

Recenti progressi in medicina

Muscari A, Puddu P.
PMID: 3299563
Recenti Prog Med. 1987 Mar;78(3):123-5.

No abstract available.

Cite
Muscari A, Puddu P. Il procedimento diagnostico, da arte a scienza: quale ruolo per il computer? [Diagnostic procedure, from art to science: what role has the computer?]. Recenti Prog Med. 1987;78(3):123-5
Muscari, A., & Puddu, P. (1987). Il procedimento diagnostico, da arte a scienza: quale ruolo per il computer? [Diagnostic procedure, from art to science: what role has the computer?]. Recenti progressi in medicina, 78(3), 123-5.
Muscari, A, and Puddu, P. "Il procedimento diagnostico, da arte a scienza: quale ruolo per il computer?" [Diagnostic procedure, from art to science: what role has the computer?]. Recenti progressi in medicina vol. 78,3 (1987): 123-5.
Muscari A, Puddu P. Il procedimento diagnostico, da arte a scienza: quale ruolo per il computer? [Diagnostic procedure, from art to science: what role has the computer?]. Recenti Prog Med. 1987 Mar;78(3):123-5. Italian. PMID: 3299563.
Copy Download .nbib Format: NLM
Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy.

Journal of robotic surgery

Bove AM, Altobelli E, Sergi F, Buscarini M.
PMID: 27637245
J Robot Surg. 2014 Mar;8(1):85-8. doi: 10.1007/s11701-013-0392-5. Epub 2013 Jan 18.

INTRODUCTION: Robot-assisted laparoscopic radical prostatectomy (RALRP) is one of the best treatment for patients with localized prostate cancer. RALRP is currently performed in patients without previous surgical treatment for benign prostatic hyperplasia. This paper presents a successfully performed RALRP...

Cite
Bove AM, Altobelli E, Sergi F, et al. Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy. J Robot Surg. 2013;8(1):85-8doi: 10.1007/s11701-013-0392-5.
Bove, A. M., Altobelli, E., Sergi, F., & Buscarini, M. (2014). Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy. Journal of robotic surgery, 8(1), 85-8. https://doi.org/10.1007/s11701-013-0392-5
Bove, Alfredo Maria, et al. "Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy." Journal of robotic surgery vol. 8,1 (2014): 85-8. doi: https://doi.org/10.1007/s11701-013-0392-5
Bove AM, Altobelli E, Sergi F, Buscarini M. Robot-assisted laparoscopic radical prostatectomy after previous open transvesical adenomectomy. J Robot Surg. 2014 Mar;8(1):85-8. doi: 10.1007/s11701-013-0392-5. Epub 2013 Jan 18. PMID: 27637245.
Copy Download .nbib Format: NLM
Robotic-assisted simple prostatectomy with clamping of bilateral hypogastric arteries.

Journal of robotic surgery

Sergi F, Falavolti C, Bove AM, Luperto E, Altobelli E, Buscarini M.
PMID: 27000929
J Robot Surg. 2013 Sep;7(3):309-10. doi: 10.1007/s11701-013-0421-4. Epub 2013 Jul 24.

To present a case of laparoscopic robotic-assisted simple prostatectomy with temporary clamping of the bilateral hypogastric arteries. A 74-year-old patient with large prostatic adenoma (> 80 ml) underwent robotic-assisted laparoscopic transvesical adenoma enucleation according to Sotelo's technique. The hypogastric...

Cite
Sergi F, Falavolti C, Bove AM, et al. Robotic-assisted simple prostatectomy with clamping of bilateral hypogastric arteries. J Robot Surg. 2013;7(3):309-10doi: 10.1007/s11701-013-0421-4.
Sergi, F., Falavolti, C., Bove, A. M., Luperto, E., Altobelli, E., & Buscarini, M. (2013). Robotic-assisted simple prostatectomy with clamping of bilateral hypogastric arteries. Journal of robotic surgery, 7(3), 309-10. https://doi.org/10.1007/s11701-013-0421-4
Sergi, Federico, et al. "Robotic-assisted simple prostatectomy with clamping of bilateral hypogastric arteries." Journal of robotic surgery vol. 7,3 (2013): 309-10. doi: https://doi.org/10.1007/s11701-013-0421-4
Sergi F, Falavolti C, Bove AM, Luperto E, Altobelli E, Buscarini M. Robotic-assisted simple prostatectomy with clamping of bilateral hypogastric arteries. J Robot Surg. 2013 Sep;7(3):309-10. doi: 10.1007/s11701-013-0421-4. Epub 2013 Jul 24. PMID: 27000929.
Copy Download .nbib Format: NLM
Luminescence mechanisms of defective ZnO nanoparticles.

Physical chemistry chemical physics : PCCP

Camarda P, Messina F, Vaccaro L, Agnello S, Buscarino G, Schneider R, Popescu R, Gerthsen D, Lorenzi R, Gelardi FM, Cannas M.
PMID: 27251452
Phys Chem Chem Phys. 2016 Jun 28;18(24):16237-44. doi: 10.1039/c6cp01513a. Epub 2016 Jun 02.

ZnO nanoparticles (NPs) synthesized by pulsed laser ablation (PLAL) of a zinc plate in deionized water were investigated by time-resolved photoluminescence (PL) and complementary techniques (TEM, AFM, μRaman). HRTEM images show that PLAL produces crystalline ZnO NPs in wurtzite...

Cite
Camarda P, Messina F, Vaccaro L, et al. Luminescence mechanisms of defective ZnO nanoparticles. Phys Chem Chem Phys. 2016;18(24):16237-44doi: 10.1039/c6cp01513a.
Camarda, P., Messina, F., Vaccaro, L., Agnello, S., Buscarino, G., Schneider, R., Popescu, R., Gerthsen, D., Lorenzi, R., Gelardi, F. M., & Cannas, M. (2016). Luminescence mechanisms of defective ZnO nanoparticles. Physical chemistry chemical physics : PCCP, 18(24), 16237-44. https://doi.org/10.1039/c6cp01513a
Camarda, Pietro, et al. "Luminescence mechanisms of defective ZnO nanoparticles." Physical chemistry chemical physics : PCCP vol. 18,24 (2016): 16237-44. doi: https://doi.org/10.1039/c6cp01513a
Camarda P, Messina F, Vaccaro L, Agnello S, Buscarino G, Schneider R, Popescu R, Gerthsen D, Lorenzi R, Gelardi FM, Cannas M. Luminescence mechanisms of defective ZnO nanoparticles. Phys Chem Chem Phys. 2016 Jun 28;18(24):16237-44. doi: 10.1039/c6cp01513a. Epub 2016 Jun 02. PMID: 27251452.
Copy Download .nbib Format: NLM
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.

Nature medicine

Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, Ponzetti A, Cremolini C, Amatu A, Lauricella C, Lamba S, Hobor S, Avallone A, Valtorta E, Rospo G, Medico E, Motta V, Antoniotti C, Tatangelo F, Bellosillo B, Veronese S, Budillon A, Montagut C, Racca P, Marsoni S, Falcone A, Corcoran RB, Di Nicolantonio F, Loupakis F, Siena S, Sartore-Bianchi A, Bardelli A.
PMID: 26151329
Nat Med. 2015 Jul;21(7):827. doi: 10.1038/nm0715-827b.

No abstract available.

Cite
Siravegna G, Mussolin B, Buscarino M, et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015;21(7):827doi: 10.1038/nm0715-827b.
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., Lamba, S., Hobor, S., Avallone, A., Valtorta, E., Rospo, G., Medico, E., Motta, V., Antoniotti, C., Tatangelo, F., Bellosillo, B., Veronese, S., Budillon, A., Montagut, C., Racca, P., Marsoni, S., Falcone, A., Corcoran, R. B., Di Nicolantonio, F., Loupakis, F., Siena, S., Sartore-Bianchi, A., & Bardelli, A. (2015). Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nature medicine, 21(7), 827. https://doi.org/10.1038/nm0715-827b
Siravegna, Giulia, et al. "Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients." Nature medicine vol. 21,7 (2015): 827. doi: https://doi.org/10.1038/nm0715-827b
Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, Ponzetti A, Cremolini C, Amatu A, Lauricella C, Lamba S, Hobor S, Avallone A, Valtorta E, Rospo G, Medico E, Motta V, Antoniotti C, Tatangelo F, Bellosillo B, Veronese S, Budillon A, Montagut C, Racca P, Marsoni S, Falcone A, Corcoran RB, Di Nicolantonio F, Loupakis F, Siena S, Sartore-Bianchi A, Bardelli A. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015 Jul;21(7):827. doi: 10.1038/nm0715-827b. PMID: 26151329.
Copy Download .nbib Format: NLM
In-situ monitoring by Raman spectroscopy of the thermal doping of graphene and MoS.

Beilstein journal of nanotechnology

Piazza A, Giannazzo F, Buscarino G, Fisichella G, Magna A, Roccaforte F, Cannas M, Gelardi FM, Agnello S.
PMID: 28326231
Beilstein J Nanotechnol. 2017 Feb 10;8:418-424. doi: 10.3762/bjnano.8.44. eCollection 2017.

The effects of temperature and atmosphere (air and O

Cite
Piazza A, Giannazzo F, Buscarino G, et al. In-situ monitoring by Raman spectroscopy of the thermal doping of graphene and MoS. Beilstein J Nanotechnol. 2017;8:418-424doi: 10.3762/bjnano.8.44.
Piazza, A., Giannazzo, F., Buscarino, G., Fisichella, G., Magna, A., Roccaforte, F., Cannas, M., Gelardi, F. M., & Agnello, S. (2017). In-situ monitoring by Raman spectroscopy of the thermal doping of graphene and MoS. Beilstein journal of nanotechnology, 8418-424. https://doi.org/10.3762/bjnano.8.44
Piazza, Aurora, et al. "In-situ monitoring by Raman spectroscopy of the thermal doping of graphene and MoS." Beilstein journal of nanotechnology vol. 8 (2017): 418-424. doi: https://doi.org/10.3762/bjnano.8.44
Piazza A, Giannazzo F, Buscarino G, Fisichella G, Magna A, Roccaforte F, Cannas M, Gelardi FM, Agnello S. In-situ monitoring by Raman spectroscopy of the thermal doping of graphene and MoS. Beilstein J Nanotechnol. 2017 Feb 10;8:418-424. doi: 10.3762/bjnano.8.44. eCollection 2017. PMID: 28326231; PMCID: PMC5331249.
Copy Download .nbib Format: NLM
Plasma cell-free DNA in paediatric lymphomas.

Journal of Cancer

Mussolin L, Burnelli R, Pillon M, Carraro E, Farruggia P, Todesco A, Mascarin M, Rosolen A.
PMID: 23678368
J Cancer. 2013 Apr 16;4(4):323-9. doi: 10.7150/jca.6226. Print 2013.

BACKGROUND: Extracellular circulating DNA (cfDNA) can be found in small amounts in plasma of healthy individuals. Increased levels of cfDNA have been reported in patients with cancer of breast, cervix, colon, liver and it was shown that cfDNA can...

Cite
Mussolin L, Burnelli R, Pillon M, et al. Plasma cell-free DNA in paediatric lymphomas. J Cancer. 2013;4(4):323-9doi: 10.7150/jca.6226.
Mussolin, L., Burnelli, R., Pillon, M., Carraro, E., Farruggia, P., Todesco, A., Mascarin, M., & Rosolen, A. (2013). Plasma cell-free DNA in paediatric lymphomas. Journal of Cancer, 4(4), 323-9. https://doi.org/10.7150/jca.6226
Mussolin, Lara, et al. "Plasma cell-free DNA in paediatric lymphomas." Journal of Cancer vol. 4,4 (2013): 323-9. doi: https://doi.org/10.7150/jca.6226
Mussolin L, Burnelli R, Pillon M, Carraro E, Farruggia P, Todesco A, Mascarin M, Rosolen A. Plasma cell-free DNA in paediatric lymphomas. J Cancer. 2013 Apr 16;4(4):323-9. doi: 10.7150/jca.6226. Print 2013. PMID: 23678368; PMCID: PMC3654488.
Copy Download .nbib Format: NLM
Technology for Radiofrequency Thermal Ablation of Liver Tumors.

Seminars in laparoscopic surgery

Buscarini L, Rossi S.
PMID: 10401146
Semin Laparosc Surg. 1997 Jun;4(2):96-101. doi: 10.1053/SLAS00400096.

In this review the usefulness of percutaneous radiofrequency interstitial thermal ablation of liver cancer has been evaluated. The technique has been recently improved by using modified needle electrodes (eg, expandable needle, cooled needle) that allow the ablation of tumors...

Cite
Buscarini L, Rossi S. Technology for Radiofrequency Thermal Ablation of Liver Tumors. Semin Laparosc Surg. 1997;4(2):96-101doi: 10.1053/SLAS00400096.
Buscarini, L., & Rossi, S. (1997). Technology for Radiofrequency Thermal Ablation of Liver Tumors. Seminars in laparoscopic surgery, 4(2), 96-101. https://doi.org/10.1053/SLAS00400096
Buscarini, and Rossi. "Technology for Radiofrequency Thermal Ablation of Liver Tumors." Seminars in laparoscopic surgery vol. 4,2 (1997): 96-101. doi: https://doi.org/10.1053/SLAS00400096
Buscarini L, Rossi S. Technology for Radiofrequency Thermal Ablation of Liver Tumors. Semin Laparosc Surg. 1997 Jun;4(2):96-101. doi: 10.1053/SLAS00400096. PMID: 10401146.
Copy Download .nbib Format: NLM
Effects of Corticotrophin Releasing Factor, Muscarine and Somatostatin on Rubidium and Potassium Efflux from Mouse AtT-20 Pituitary Cells.

The European journal of neuroscience

Luini A, Brown DA.
PMID: 12106055
Eur J Neurosci. 1990 Feb;2(2):126-131. doi: 10.1111/j.1460-9568.1990.tb00404.x.

Effects of secretagogues and anti-secretagogues of ACTH secretion on K+ permeability in the clonal pituitary cell line AtT-20 were measured by recording 86Rb or 42K efflux. Efflux was accelerated by the secretagogues K+, corticotrophin, forskolin, isoprenaline, and the Ca-ionophore...

Cite
Luini A, Brown DA. Effects of Corticotrophin Releasing Factor, Muscarine and Somatostatin on Rubidium and Potassium Efflux from Mouse AtT-20 Pituitary Cells. Eur J Neurosci. 1990;2(2):126-131doi: 10.1111/j.1460-9568.1990.tb00404.x.
Luini, A., & Brown, D. A. (1990). Effects of Corticotrophin Releasing Factor, Muscarine and Somatostatin on Rubidium and Potassium Efflux from Mouse AtT-20 Pituitary Cells. The European journal of neuroscience, 2(2), 126-131. https://doi.org/10.1111/j.1460-9568.1990.tb00404.x
Luini, A., and Brown, D. A.. "Effects of Corticotrophin Releasing Factor, Muscarine and Somatostatin on Rubidium and Potassium Efflux from Mouse AtT-20 Pituitary Cells." The European journal of neuroscience vol. 2,2 (1990): 126-131. doi: https://doi.org/10.1111/j.1460-9568.1990.tb00404.x
Luini A, Brown DA. Effects of Corticotrophin Releasing Factor, Muscarine and Somatostatin on Rubidium and Potassium Efflux from Mouse AtT-20 Pituitary Cells. Eur J Neurosci. 1990 Feb;2(2):126-131. doi: 10.1111/j.1460-9568.1990.tb00404.x. PMID: 12106055.
Copy Download .nbib Format: NLM
Dynamical network model of infective mobile agents.

Physical review. E, Statistical, nonlinear, and soft matter physics

Frasca M, Buscarino A, Rizzo A, Fortuna L, Boccaletti S.
PMID: 17025711
Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Sep;74(3):036110. doi: 10.1103/PhysRevE.74.036110. Epub 2006 Sep 21.

A dynamical network (consisting of a time-evolving wiring of interactions among a group of random walkers) is introduced to model the spread of an infectious disease in a population of mobile individuals. We investigate the main properties of this...

Cite
Frasca M, Buscarino A, Rizzo A, et al. Dynamical network model of infective mobile agents. Phys Rev E Stat Nonlin Soft Matter Phys. 2006;74(3):036110doi: 10.1103/PhysRevE.74.036110.
Frasca, M., Buscarino, A., Rizzo, A., Fortuna, L., & Boccaletti, S. (2006). Dynamical network model of infective mobile agents. Physical review. E, Statistical, nonlinear, and soft matter physics, 74(3), 036110. https://doi.org/10.1103/PhysRevE.74.036110
Frasca, Mattia, et al. "Dynamical network model of infective mobile agents." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 74,3 (2006): 036110. doi: https://doi.org/10.1103/PhysRevE.74.036110
Frasca M, Buscarino A, Rizzo A, Fortuna L, Boccaletti S. Dynamical network model of infective mobile agents. Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Sep;74(3):036110. doi: 10.1103/PhysRevE.74.036110. Epub 2006 Sep 21. PMID: 17025711.
Copy Download .nbib Format: NLM
A survey of five antidepressant properties influencing clinician's treatment choices in MDD.

Neuropsychiatric disease and treatment

Papakostas GI, Hallett LA, Smith J, Tossani E, Mascarini A, Burns AM, Birnbaum RJ, Fava M, Alpert JE.
PMID: 19300547
Neuropsychiatr Dis Treat. 2007 Feb;3(1):169-72. doi: 10.2147/nedt.2007.3.1.169.

INTRODUCTION: The goal of the present work was to examine how clinicians' perceptions of the properties of antidepressants may influence their choice of antidepressants when treating major depressive disorder (MDD).METHODS: 273 of 682 (40%) clinicians attending a psychopharmacology review...

Cite
Papakostas GI, Hallett LA, Smith J, et al. A survey of five antidepressant properties influencing clinician's treatment choices in MDD. Neuropsychiatr Dis Treat. 2007;3(1):169-72doi: 10.2147/nedt.2007.3.1.169.
Papakostas, G. I., Hallett, L. A., Smith, J., Tossani, E., Mascarini, A., Burns, A. M., Birnbaum, R. J., Fava, M., & Alpert, J. E. (2007). A survey of five antidepressant properties influencing clinician's treatment choices in MDD. Neuropsychiatric disease and treatment, 3(1), 169-72. https://doi.org/10.2147/nedt.2007.3.1.169
Papakostas, George I, et al. "A survey of five antidepressant properties influencing clinician's treatment choices in MDD." Neuropsychiatric disease and treatment vol. 3,1 (2007): 169-72. doi: https://doi.org/10.2147/nedt.2007.3.1.169
Papakostas GI, Hallett LA, Smith J, Tossani E, Mascarini A, Burns AM, Birnbaum RJ, Fava M, Alpert JE. A survey of five antidepressant properties influencing clinician's treatment choices in MDD. Neuropsychiatr Dis Treat. 2007 Feb;3(1):169-72. doi: 10.2147/nedt.2007.3.1.169. PMID: 19300547; PMCID: PMC2654520.
Copy Download .nbib Format: NLM
Rivastigmine in the treatment of patients with Alzheimer's disease.

Neuropsychiatric disease and treatment

Müller T.
PMID: 19300554
Neuropsychiatr Dis Treat. 2007 Apr;3(2):211-8. doi: 10.2147/nedt.2007.3.2.211.

Impairment of attention and memory in patients with Alzheimer's disease (AD) is associated with significantly lower levels of acetylcholine. Inhibition of the breakdown of acetylcholine by blocking the enzymes acetylcholinesterase and butyrylcholinesterase with rivastigmine improves this cholinergic depletion. Thus...

Cite
Müller T. Rivastigmine in the treatment of patients with Alzheimer's disease. Neuropsychiatr Dis Treat. 2007;3(2):211-8doi: 10.2147/nedt.2007.3.2.211.
Müller, T. (2007). Rivastigmine in the treatment of patients with Alzheimer's disease. Neuropsychiatric disease and treatment, 3(2), 211-8. https://doi.org/10.2147/nedt.2007.3.2.211
Müller, Thomas. "Rivastigmine in the treatment of patients with Alzheimer's disease." Neuropsychiatric disease and treatment vol. 3,2 (2007): 211-8. doi: https://doi.org/10.2147/nedt.2007.3.2.211
Müller T. Rivastigmine in the treatment of patients with Alzheimer's disease. Neuropsychiatr Dis Treat. 2007 Apr;3(2):211-8. doi: 10.2147/nedt.2007.3.2.211. PMID: 19300554; PMCID: PMC2654625.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 205 entries